Development of paclitaxel and flurbiprofen coloaded PLGA nanoparticles: understanding critical formulation and process parameters using Plackett– Burman design

References (4)

1. Acharya, S., & Sahoo, S. K. (2011). PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Advanced Drug Delivery Reviews, 63(3), 170-183. doi:https://doi.org/10.1016/j.addr.2010.10.008
2. Collnot, E. M., Baldes, C., Schaefer, U. F., Edgar, K. J., Wempe, M. F., & Lehr, C. M. (2010). Vitamin E TPGS P-glycoprotein inhibition mechanism: influence on conformational flexibility, intracellular ATP levels, and role of time and site of access. Mol Pharm, 7(3), 642-651. doi:10.1021/mp900191s Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Preat, V. (2012). PLGA-based nanoparticles: an overview of biomedical applications. J Control Release, 161(2), 505-522. doi:10.1016/j.jconrel.2012.01.043 Dinarvand, R., Sepehri, N., Manoochehri, S., Rouhani, H., & Atyabi, F. (2011). Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents. Int J Nanomedicine, 6, 877-895. doi:10.2147/ijn.s18905 Gaonkar, R. H., Ganguly, S., Dewanjee, S., Sinha, S., Gupta, A., Ganguly, S.,. Chatterjee Debnath, M. (2017). Garcinol loaded vitamin E TPGS emulsified PLGA nanoparticles: preparation, physicochemical characterization, in vitro and in vivo studies. Scientific Reports, 7(1), 530. doi:10.1038/s41598-017-00696-6
3. Hillaireau, H., & Couvreur, P. (2009). Nanocarriers' entry into the cell: relevance to drug delivery. Cell Mol Life Sci, 66(17), 2873-2896. doi:10.1007/s00018-009-0053-z Jin, H., Wang, Z., Liu, L., Gao, L., Sun, L., Li, X.,. Fan, D. (2010). R-flurbiprofen reverses multidrug resistance, proliferation and metastasis in gastric cancer cells by p75(NTR) induction. Mol Pharm, 7(1), 156-168. doi:10.1021/mp900189x Jin, H., Wang, Z., Liu, L., Gao, L., Sun, L., Li, X.,. Fan, D. (2010). R-Flurbiprofen Reverses Multidrug Resistance, Proliferation and Metastasis in Gastric Cancer Cells by p75NTR Induction. Molecular Pharmaceutics, 7(1), 156-168. doi:10.1021/mp900189x Kozlu, S., Sahin, A., Ultav, G., Yerlikaya, F., Calis, S., & Capan, Y. (2018). Development and in vitro evaluation of doxorubicin and celecoxib co-loaded bone targeted nanoparticles. Journal of Drug Delivery Science and Technology, 45, 213-219. doi:https://doi.org/10.1016/j.jddst.2018.02.004
4. Liu, J. K., Patel, S. K., Gillespie, D. L., Whang, K., & Couldwell, W. T. (2012). R-flurbiprofen, a novel nonsteroidal anti-inflammatory drug, decreases cell proliferation and induces apoptosis in pituitary adenoma cells in vitro. J Neurooncol, 106(3), 56